RaySearch Laboratories:
JANUARY 1 - JUNE 30, 2011
· Net sales for the period totaled SEK 47.6 M (60.9)
· Profit after tax was SEK 1.3 M (17.4) corresponding to earnings per share of SEK 0.04 (0.51)
· Operating profit totaled SEK 2.0 M (23.8) · Cash flow was a negative SEK 27.0 M (pos: 2.1)
· RaySearch established a sales organization in the US in January
· Two new orders for RayStation® from Switzerland and Canada were received in February
· RaySearch licensed pioneering technology from Princess Margaret Hospital in March
· A clinic in the Netherlands placed an order for RayStation® in April
· RaySearch became involved in a US patent dispute in May
AFTER THE END OF THE PERIOD
· Three US cancer centers placed orders for RayStation® in August
"Financially, the first six months of the year were weak. The profit is declining faster than the revenues due to the investment in our proprietary RayStation® treatment planning system where costs were incurred for development, marketing and the build-up of the sales and service organizations, but we have not yet benefitted from significant revenues from the product," says Johan Löf, President of RaySearch.
"We are however starting to see results from our RayStation® sales effort. In August, we announced three new orders from clinics in New Jersey and New York with a combined order value exceeding one million US dollars," concludes Johan Löf.